5-Aminolevulinic acid hydrochloride enhances bupivacaine-induced hypotension in spontaneously hypertensive rats

Purpose: Oral administration of 5-aminolevulinic acid hydrochloride (5-ALA-HCl) has been reported to enhance the hypotensive effects associated with anesthetics, especially in elderly hypertensive patients treated with antihypertensive agents. The present study aimed to clarify the effects of antihy...

Full description

Saved in:
Bibliographic Details
Main Authors: Noboru Fukuda (Author), Mayumi Katakawa (Author), Hidenori Ito (Author), Takeshi Hara (Author), Noboru Otsuka (Author), Masahiro Ishizuka (Author), Masanori Abe (Author)
Format: Book
Published: Elsevier, 2023-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_fa7f88a2565b4cfb9e0643adb5bdea3e
042 |a dc 
100 1 0 |a Noboru Fukuda  |e author 
700 1 0 |a Mayumi Katakawa  |e author 
700 1 0 |a Hidenori Ito  |e author 
700 1 0 |a Takeshi Hara  |e author 
700 1 0 |a Noboru Otsuka  |e author 
700 1 0 |a Masahiro Ishizuka  |e author 
700 1 0 |a Masanori Abe  |e author 
245 0 0 |a 5-Aminolevulinic acid hydrochloride enhances bupivacaine-induced hypotension in spontaneously hypertensive rats 
260 |b Elsevier,   |c 2023-05-01T00:00:00Z. 
500 |a 1347-8613 
500 |a 10.1016/j.jphs.2023.02.007 
520 |a Purpose: Oral administration of 5-aminolevulinic acid hydrochloride (5-ALA-HCl) has been reported to enhance the hypotensive effects associated with anesthetics, especially in elderly hypertensive patients treated with antihypertensive agents. The present study aimed to clarify the effects of antihypertensive-agent- and anesthesia-induced hypotension by 5-ALA-HCl in spontaneously hypertensive rats (SHRs). Methods: We measured blood pressure (BP) of SHRs and normotensive Wistar Kyoto (WKY) rats treated with amlodipine or candesartan before and after administration of 5-ALA-HCl. We also investigated the change in BP following intravenous infusion of propofol and intrathecal injection of bupivacaine in relation to 5-ALA-HCl administration. Findings: Oral administration of 5-ALA-HCl significantly reduced BP in SHRs and WKY rats with amlodipine and candesartan. Infusion of propofol significantly reduced BP in SHRs treated with 5-ALA-HCl. Intrathecal injection of bupivacaine significantly declined SBP and DBP in both SHRs and WKY rats treated with 5-ALA-HCl. The bupivacaine-induced decline in SBP was significantly larger in SHRs compared with WKY rats. Conclusion: These findings suggest that 5-ALA-HCl does not affect the antihypertensive agents-induced hypotensive effect, but enhances the bupivacaine-induced hypotensive effect, especially in SHRs, indicating that 5-ALA may contribute to anesthesia-induced hypotension via suppression of sympathetic nerve activity in patients with hypertension. 
546 |a EN 
690 |a 5-Aminolevulinic acid 
690 |a Hypotension 
690 |a Bupivacaine 
690 |a Propofol 
690 |a Spontaneous hypertensive rats 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmacological Sciences, Vol 152, Iss 1, Pp 22-29 (2023) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S1347861323000142 
787 0 |n https://doaj.org/toc/1347-8613 
856 4 1 |u https://doaj.org/article/fa7f88a2565b4cfb9e0643adb5bdea3e  |z Connect to this object online.